BIOMAT Database Logo BIOMAT Database Logo

Introduction of pneumococcal conjugate vaccine into the Dutch national immunisation programme. 2006

M van Oosten, and S C de Greeff, and L Spanjaard, and L M Schouls
Centre for Infectious Disease Control, National Institute of Public Health and the Environment, Bilthoven, The Netherlands. marijke.van.oosten@rivm.nl

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D008297 Male Males
D008586 Meningitis, Pneumococcal An acute purulent infection of the meninges and subarachnoid space caused by Streptococcus pneumoniae, most prevalent in children and adults over the age of 60. This illness may be associated with OTITIS MEDIA; MASTOIDITIS; SINUSITIS; RESPIRATORY TRACT INFECTIONS; sickle cell disease (ANEMIA, SICKLE CELL); skull fractures; and other disorders. Clinical manifestations include FEVER; HEADACHE; neck stiffness; and somnolence followed by SEIZURES; focal neurologic deficits (notably DEAFNESS); and COMA. (From Miller et al., Merritt's Textbook of Neurology, 9th ed, p111) Meningitis, Streptococcus pneumoniae,Experimental Pneumococcal Meningitis,Meningitis, Pneumococcal, Experimental,Meningitis, Pneumococcal, Penicillin-Resistant,Meningitis, Pneumococcal, Recurrent,Experimental Pneumococcal Meningitides,Meningitides, Streptococcus pneumoniae,Meningitis, Experimental Pneumococcal,Pneumococcal Meningitides,Pneumococcal Meningitides, Experimental,Pneumococcal Meningitis,Pneumococcal Meningitis, Experimental,Streptococcus pneumoniae Meningitides,Streptococcus pneumoniae Meningitis
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009426 Netherlands Country located in EUROPE. It is bordered by the NORTH SEA, BELGIUM, and GERMANY. Constituent areas are Aruba, Curacao, and Sint Maarten, formerly included in the NETHERLANDS ANTILLES. Holland,Kingdom of the Netherlands
D011159 Population Surveillance Ongoing scrutiny of a population (general population, study population, target population, etc.), generally using methods distinguished by their practicability, uniformity, and frequently their rapidity, rather than by complete accuracy. Surveillance, Population
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D003140 Communicable Disease Control Programs of surveillance designed to prevent the transmission of disease by any means from person to person or from animal to man. Flatten the Curve of Epidemic,Flattening the Curve, Communicable Disease Control,Parasite Control,Control, Communicable Disease,Control, Parasite

Related Publications

M van Oosten, and S C de Greeff, and L Spanjaard, and L M Schouls
Effectiveness of pneumococcal conjugate vaccine and rotavirus vaccine introduction into the South African public immunisation programme.
March 2014, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
M van Oosten, and S C de Greeff, and L Spanjaard, and L M Schouls
Introduction of pneumococcal conjugate vaccine into the Norwegian childhood vaccination programme.
February 2006, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin,
M van Oosten, and S C de Greeff, and L Spanjaard, and L M Schouls
ENT/Audiology Department of Samoa welcomes the introduction of the Pneumococcal Conjugate Vaccine (PCV) into the national childhood immunisation program.
May 2022, Journal of global health,
M van Oosten, and S C de Greeff, and L Spanjaard, and L M Schouls
Monitoring of community-acquired pneumonia hospitalisations before the introduction of pneumococcal conjugate vaccine into Polish National Immunisation Programme (2009-2016): A nationwide retrospective database analysis.
January 2020, Vaccine,
M van Oosten, and S C de Greeff, and L Spanjaard, and L M Schouls
Introduction of a hepatitis B vaccine into the national routine immunisation programme of Japan.
December 2016, The Lancet. Infectious diseases,
M van Oosten, and S C de Greeff, and L Spanjaard, and L M Schouls
Introduction of pneumococcal conjugate vaccine to the UK childhood immunisation programme, and changes to the meningitis C and Hib schedules.
March 2006, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin,
M van Oosten, and S C de Greeff, and L Spanjaard, and L M Schouls
Immunogenicity of a hexavalent vaccine co-administered with 7-valent pneumococcal conjugate vaccine. Findings from the National Immunisation Programme in The Netherlands.
June 2012, Human vaccines & immunotherapeutics,
M van Oosten, and S C de Greeff, and L Spanjaard, and L M Schouls
Pneumococcal meningitis before the introduction of 10-valent pneumococcal conjugate vaccine into the National Childhood Immunization Program in Poland.
February 2019, Vaccine,
M van Oosten, and S C de Greeff, and L Spanjaard, and L M Schouls
Epidemiology of hospitalised paediatric community-acquired pneumonia and bacterial pneumonia following the introduction of 13-valent pneumococcal conjugate vaccine in the national immunisation programme in Japan.
April 2020, Epidemiology and infection,
M van Oosten, and S C de Greeff, and L Spanjaard, and L M Schouls
Immunisation with a pneumococcal 7-valent conjugate vaccine.
May 2002, International journal of clinical practice,
Copied contents to your clipboard!